v3.23.1

Balance Sheets - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 765,782	$ 836,874
Prepaid expenses	71,506	774,677
Income tax receivable	174,922
Total current assets	1,012,210	1,611,551
Investments held in Trust Account	94,326,613	862,549,773
Total Assets	95,338,823	864,161,324
Current liabilities:
Accounts payable	4,189	8,047
Accrued expenses		162,917
Franchise tax payable	40,000	200,045
Due to related party	400,000
Convertible Promissory note – related party - short term	182,010
Promissory note – related party	750,000
Total current liabilities	1,376,199	371,009
Derivative warrant liabilities	3,783,550	30,268,330
Deferred underwriting commissions		30,187,500
Convertible Promissory note – related party - long term		1,392,950
Deferred legal costs	4,046,016	957,588
Total liabilities	9,205,765	63,177,377
Commitments and Contingencies
Class A common stock subject to possible redemption, $0.0001 par value; 9,223,194 shares issued and outstanding at $10.24 at December 31, 2022 and 86,250,000 shares issued and outstanding $10.00 per share redemption value at December 31, 2021	94,401,540	862,500,000
Stockholders’ Deficit:
Preferred stock, $0.0001 par value; 3,000,000 shares authorized; none issued or outstanding at December 31, 2022 and December 31, 2021
Class A common stock, $0.0001 par value; 300,000,000 shares authorized; no non-redeemable shares issued or outstanding at December 31, 2022 and December 31, 2021
Class B common stock, $0.0001 par value; 30,000,000 shares authorized; 21,562,500 shares issued and outstanding at December 31, 2022 and December 31, 2021	2,156	2,156
Additional paid-in capital
Accumulated deficit	(8,270,638)	(61,518,209)
Total stockholders’ deficit	(8,268,482)	(61,516,053)
Total Liabilities, Class A Common Stock Subject to Possible Redemption and Stockholders’ Deficit	$ 95,338,823	$ 864,161,324

Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.

+ References

No definition available.

Compute Health Acquisition Corp. 10-K